The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa

References

• Caaveiro JMM, Kiyoshi M, Tsumoto K. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design. Immunol Rev. 2015;268(1):201–15. doi:10.1111/imr.12365. PMID: 26497522.
   PubMed Web of Science ®Google Scholar
• Shields RL, Lai J, Keck R, O’Connell LY, Hong K, Gloria Meng Y, Weikert SHA, Presta LG. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity. J Biol Chem. 2002;277(30):26733–40. doi:10.1074/jbc.M202069200. PMID: 11986321.
   PubMed Web of Science ®Google Scholar
• Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem. 2003;278(5):3466–73. doi:10.1074/jbc.M210665200. PMID: 12427744.
   PubMed Web of Science ®Google Scholar
• Okazaki A, Shoji-Hosaka E, Nakamura K, Wakitani M, Uchida K, Kakita S, Tsumoto K, Kumagai I, Shitara K. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa. J Mol Biol. 2004;336(5):1239–49. doi:10.1016/j.jmb.2004.01.007. PMID: 15037082.
   PubMed Web of Science ®Google Scholar
• Subedi GP, Barb AW. The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor. MAbs. 2016;8(8):1512–24. doi:10.1080/19420862.2016.1218586. PMID: 27492264.
   PubMed Web of Science ®Google Scholar
• Dekkers G, Treffers L, Plomp R, Bentlage AEH, de Boer M, Koeleman CAM, Lissenberg-Thunnissen SN, Visser R, Brouwer M, Jy M, et al. Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor- and complement-mediated-effector activities. Front Immunol. 2017;8:877. doi:10.3389/fimmu.2017.00877. PMID: 28824618.
   PubMed Web of Science ®Google Scholar
• Shields RL, Namenuk AK, Hong K, Meng YG, Rae J, Briggs J, Xie D, Lai J, Stadlen A, Li B, et al. High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J Biol Chem. 2001;276(9):6591–604. doi:10.1074/jbc.M009483200. PMID: 11096108.
   PubMed Web of Science ®Google Scholar
• Mimoto F, Igawa T, Kuramochi T, Katada H, Kadono S, Kamikawa T, Shida-Kawazoe M, Hattori K. Novel asymmetrically engineered antibody Fc variant with superior FcγR binding affinity and specificity compared with afucosylated Fc variant. MAbs. 2013;5(2):229–36. doi:10.4161/mabs.23452. PMID: 23406628.
   PubMed Web of Science ®Google Scholar
• Krayukhina E, Noda M, Ishii K, Maruno T, Wakabayashi H, Tada M, Suzuki T, Ishii-Watabe A, Kato M, Uchiyama S. Analytical ultracentrifugation with fluorescence detection system reveals differences in complex formation between recombinant human TNF and different biological TNF antagonists in various environments. MAbs. 2017;9(4):664–79. doi:10.1080/19420862.2017.1297909. PMID: 28387583.
   PubMed Web of Science ®Google Scholar
• Tada M, Aoyama M, Ishii-Watabe A. Fcγ receptor activation by human monoclonal antibody aggregates. J Pharm Sci. 2020;109(1):576–83. doi:10.1016/j.xphs.2019.10.046. PMID: 31676270.
   PubMed Web of Science ®Google Scholar
• Krayukhina E, Yokoyama M, Hayashihara KK, Maruno T, Noda M, Watanabe H, Uchihashi T, Uchiyama S. An assessment of the ability of submicron- and micron-size silicone Oil Droplets in dropped prefillable syringes to invoke early- and late-stage immune responses. J Pharm Sci. 2019;108(7):2278–87. doi:10.1016/j.xphs.2019.02.002. PMID: 30790580.
   PubMed Web of Science ®Google Scholar
• Sondermann P, Huber R, Oosthulzen V, Jacob U. The 3.2-Å crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature. 2000;406(6793):267–73. doi:10.1038/35018508. PMID: 10917521.
   PubMed Web of Science ®Google Scholar
• Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD. The structure of a human Type III Fcγ receptor in complex with Fc. J Biol Chem. 2001;276(19):16469–77. doi:10.1074/jbc.M100350200. PMID: 11297532.
   PubMed Web of Science ®Google Scholar
• Mizushima T, Yagi H, Takemoto E, Shibata-Koyama M, Isoda Y, Iida S, Masuda K, Satoh M, Kato K. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans. Genes to Cells. 2011;16(11):1071–80. doi:10.1111/j.1365-2443.2011.01552.x. PMID: 22023369.
   PubMed Web of Science ®Google Scholar
• Ferrara C, Grau S, Jäger C, Sondermann P, Brünker P, Waldhauer I, Hennig M, Ruf A, Rufer AC, Stihle M, et al. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose. Proc Natl Acad Sci U S A. 2011;108(31):12669–74. doi:10.1073/pnas.1108455108. PMID: 21768335.
   PubMed Web of Science ®Google Scholar
• Mimoto F, Kadono S, Katada H, Igawa T, Kamikawa T, Hattori K. Crystal structure of a novel asymmetrically engineered Fc variant with improved affinity for FcγRs. Mol Immunol. 2014;58(1):132–38. doi:10.1016/j.molimm.2013.11.017. PMID: 24334029.
   PubMed Web of Science ®Google Scholar
• Ahmed AA, Keremane SR, Vielmetter J, Bjorkman PJ. Structural characterization of GASDALIE Fc bound to the activating Fc receptor FcγRIIIa. J Struct Biol. 2016;194(1):78–89. doi:10.1016/j.jsb.2016.02.001. PMID: 26850169.
   PubMed Web of Science ®Google Scholar
• Sakae Y, Satoh T, Yagi H, Yanaka S, Yamaguchi T, Isoda Y, Iida S, Okamoto Y, Kato K. Conformational effects of N-glycan core fucosylation of immunoglobulin G Fc region on its interaction with Fcγ receptor IIIa. Sci Rep. 2017;7(1):1–10. doi:10.1038/s41598-017-13845-8. PMID: 29062024.
   PubMedGoogle Scholar
• Falconer DJ, Subedi GP, Marcella AM, Barb AW. Antibody fucosylation lowers the FcγRIIIa/CD16a affinity by limiting the conformations sampled by the N162-glycan. ACS Chem Biol. 2018;13(8):2179–89. doi:10.1021/acschembio.8b00342. PMID: 30016589.
   PubMed Web of Science ®Google Scholar
• Kiyoshi M, Caaveiro JMM, Tada M, Tamura H, Tanaka T, Terao Y, Morante K, Harazono A, Hashii N, Shibata H, et al. Assessing the heterogeneity of the Fc-glycan of a therapeutic antibody using an engineered FcγReceptor IIIa-immobilized column. Sci Rep. 2018;8(1):3955. doi:10.1038/s41598-018-22199-8. PMID: 29500371.
   PubMedGoogle Scholar
• Yogo R, Yamaguchi Y, Watanabe H, Yagi H, Satoh T, Nakanishi M, Onitsuka M, Omasa T, Shimada M, Maruno T, et al. The Fab portion of immunoglobulin G contributes to its binding to Fcγ receptor III. Sci Rep. 2019;9(1):11957. doi:10.1038/s41598-019-48323-w. PMID: 31420591.
   PubMedGoogle Scholar
• Shi L, Liu T, Gross ML, Huang Y. Recognition of human IgG1 by Fcγ receptors: structural insights from hydrogen-deuterium exchange and fast photochemical oxidation of proteins coupled with mass spectrometry. Biochemistry. 2019;58(8):1074–80. doi:10.1021/acs.biochem.8b01048. PMID: 30666863.
   PubMed Web of Science ®Google Scholar
• Sun Y, Izadi S, Callahan M, Deperalta G, Wecksler AT. Antibody–receptor interactions mediate antibody-dependent cellular cytotoxicity. J Biol Chem. 2021;297(1):100826. doi:10.1016/j.jbc.2021.100826. PMID: 34044019.
   PubMed Web of Science ®Google Scholar
• Kralj S, Hodošček M, Podobnik B, Kunej T, Bren U, Janežič D, Konc J. Molecular dynamics simulations reveal interactions of an IgG1 antibody with selected Fc receptors. Front Chem. 2021;9:705931. doi:10.3389/fchem.2021.705931. PMID: 34277572.
   PubMed Web of Science ®Google Scholar
• Matsumiya S, Yamaguchi Y, Saito JI, Nagano M, Sasakawa H, Otaki S, Satoh M, Shitara K, Kato K. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol. 2007;368(3):767–79. doi:10.1016/j.jmb.2007.02.034. PMID: 17368483.
   PubMed Web of Science ®Google Scholar
• Burnouf D, Ennifar E, Guedich S, Puffer B, Hoffmann G, Bec G, Disdier F, Baltzinger M, Dumas P. KinITC: a new method for obtaining joint thermodynamic and kinetic data by isothermal titration calorimetry. J Am Chem Soc. 2012;134(1):559–65. doi:10.1021/ja209057d. PMID: 22126339.
   PubMed Web of Science ®Google Scholar
• Dumas P, Ennifar E, Da Veiga C, Bec G, Palau W, Di Primo C, Piñeiro A, Sabin J, Muñoz E, Rial J. Extending ITC to Kinetics with kinITC. Methods Enzymol. 2016;567:157–80. doi:10.1016/bs.mie.2015.08.026. PMID: 26794354.
   PubMed Web of Science ®Google Scholar
• Weis DD. Recommendations for the propagation of uncertainty in hydrogen exchange-mass spectrometric measurements. J Am Soc Mass Spectrom. 2021;32(7):1610–17. doi:10.1021/jasms.0c00475. PMID: 33764776.
   PubMed Web of Science ®Google Scholar
• Saphire EO, Parren PWHI, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, and Wilson IA. Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science. 2001;293(5532):1155–59. doi:10.1126/science.1061692. PMID: 11498595.
   PubMed Web of Science ®Google Scholar
• Sela-Culang I, Alon S, Ofran Y. A systematic comparison of free and bound antibodies reveals binding-related conformational changes. J Immunol. 2012;189(10):4890–99. doi:10.4049/jimmunol.1201493. PMID: 23066154.
   PubMed Web of Science ®Google Scholar
• Zhao J, Nussinov R, Ma B. Antigen binding allosterically promotes Fc receptor recognition. MAbs. 2019;11(1):58–74. doi:10.1080/19420862.2018.1522178. PMID: 30212263.
   PubMed Web of Science ®Google Scholar
• Orlandi C, Deredge D, Ray K, Gohain N, Tolbert W, DeVico AL, Wintrode P, Pazgier M, Lewis GK. Antigen-induced allosteric changes in a human IgG1 Fc increase low-affinity Fcγ receptor binding. Structure. 2020;28(5):516–527.e5. doi:10.1016/j.str.2020.03.001. PMID: 32209433.
   PubMed Web of Science ®Google Scholar
• Honorato RV, Koukos PI, Jiménez-García B, Tsaregorodtsev A, Verlato M, Giachetti A, Rosato A, Bonvin AMJJ. Structural biology in the clouds: the WeNMR-EOSC ecosystem. Front Mol Biosci. 2021;8:72953. doi:10.3389/fmolb.2021.729513. PMID: 34395534.
   Web of Science ®Google Scholar
• Van Zundert GCP, Rodrigues JPGLM, Trellet M, Schmitz C, Kastritis PL, Karaca E, Melquiond ASJ, Van Dijk M, De Vries SJ, Bonvin AMJJ. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016;428(4):720–25. doi:10.1016/j.jmb.2015.09.014. PMID: 26410586.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang L, Tong H, Peng B, Rames MJ, Zhang S, Ren G. 3D structural fluctuation of IgG1 antibody revealed by individual particle electron tomography. Sci Rep. 2015;5(1):09803. doi:10.1038/srep09803. PMID: 25940394.
   PubMedGoogle Scholar
• Jay J, Bray B, Qi Y, Igbinigie E, Wu H, Li J, Ren G. IgG Antibody 3D Structures and Dynamics. Antibodies. 2018;7(2):18. doi:10.3390/antib7020018. PMID: 31544870.
   Web of Science ®Google Scholar
• Houde D, Peng Y, Berkowitz SA, Engen JR. Post-translational modifications differentially affect IgG1 conformation and receptor binding. Mol Cell Proteomics. 2010;9(8):1716–28. doi:10.1074/mcp.M900540-MCP200. PMID: 20103567.
   PubMed Web of Science ®Google Scholar
• Yanaka S, Yogo R, Inoue R, Sugiyama M, Itoh SG, Okumura H, Miyanoiri Y, Yagi H, Satoh T, Yamaguchi T, et al. Dynamic views of the Fc region of immunoglobulin G provided by experimental and computational observations. Antibodies. 2019;8(3):39. doi:10.3390/antib8030039.
   Web of Science ®Google Scholar
• Latypov RF, Hogan S, Lau H, Gadgil H, Liu D. Elucidation of acid-induced unfolding and aggregation of human immunoglobulin IgG1 and IgG2 Fc. J Biol Chem. 2012;287(2):1381–96. doi:10.1074/jbc.M111.297697. PMID: 22084250.
   PubMed Web of Science ®Google Scholar
• Noda M, Ishii K, Yamauchi M, Oyama H, Tadokoro T, Maenaka K, Torisu T, Uchiyama S. Identification of IgG1 aggregation initiation region by hydrogen deuterium mass spectrometry. J Pharm Sci. 2019;108(7):2323–33. doi:10.1016/j.xphs.2019.02.023. PMID: 30851343.
   PubMed Web of Science ®Google Scholar
• Diebolder CA, Beurskens FJ, De Jong RN, Koning RI, Strumane K, Lindorfer MA, Voorhorst M, Ugurlar D, Rosati S, Heck AJR, et al. Complement is activated by IgG hexamers assembled at the cell surface. Science (80-). 2014;343(6176):1260–63. doi:10.1126/science.1248943. PMID: 24626930.
   PubMed Web of Science ®Google Scholar
• Wang G, de Jong RN, van den Bremer ETJ, Beurskens FJ, Labrijn AF, Ugurlar D, Gros P, Schuurman J, Parren PWHI, Heck AJR. Molecular basis of assembly and activation of complement component C1 in complex with immunoglobulin G1 and antigen. Mol Cell. 2016;63(1):135–45. doi:10.1016/j.molcel.2016.05.016. PMID: 27320199.
   PubMed Web of Science ®Google Scholar
• Al Qaraghuli MM, Kubiak-Ossowska K, Ferro VA, Mulheran PA. Antibody-protein binding and conformational changes: identifying allosteric signalling pathways to engineer a better effector response. Sci Rep. 2020;10(1):1–10. doi:10.1038/s41598-020-70680-0. PMID: 32792612.
   PubMed Web of Science ®Google Scholar
• Sun Y, Estevez A, Schlothauer T, Wecksler AT. Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity. MAbs. 2020;12(1):1–9. doi:10.1080/19420862.2020.1802135. PMID: 32795110.
   Web of Science ®Google Scholar
• Reusch U, Burkhardt C, Fucek I, Le Gall F, Le Gall M, Hoffmann K, Knackmuss SHJ, Kiprijanov S, Little M, Zhukovsky EA. A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30 + tumor cells. MAbs. 2014;6(3):727–38. doi:10.4161/mabs.28591. PMID: 24670809.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Ahmed M, Tassev DV, Hasan A, Kuo TY, Guo HF, O’Reilly RJ, Cheung NKV. Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential. Leukemia. 2015;29(11):2238–47. doi:10.1038/leu.2015.125. PMID: 25987253.
   PubMed Web of Science ®Google Scholar
• Teeling JL, French RR, Cragg MS, Van Den Brakel J, Pluyter M, Huang H, Chan C, Parren PWHI, Hack CE, Dechant M, et al. Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas. Blood. 2004;104(6):1793–800. doi:10.1182/blood-2004-01-0039. PMID: 15172969.
   PubMed Web of Science ®Google Scholar
• Majumdar R, Manikwar P, Hickey JM, Arora J, Middaugh CR, Volkin DB, Weis DD. Minimizing carry-over in an online pepsin digestion system used for the H/D exchange mass spectrometric analysis of an IgG1 monoclonal antibody. J Am Soc Mass Spectrom. 2012;23(12):2140–48. doi:10.1007/s13361-012-0485-9. PMID: 22993047.
   PubMed Web of Science ®Google Scholar
• Masson GR, Burke JE, Ahn NG, Anand GS, Borchers C, Brier S, Bou-Assaf GM, Engen JR, Englander SW, Faber J, et al. Recommendations for performing, interpreting and reporting hydrogen deuterium exchange mass spectrometry (HDX-MS) experiments. Nat Methods. 2019;16(7):595–602. doi:10.1038/s41592-019-0459-y. PMID: 31249422.
   PubMed Web of Science ®Google Scholar
• Goddard TD, Huang CC, Meng EC, Pettersen EF, Couch GS, Morris JH, Ferrin TE. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 2018;27(1):14–25. doi:10.1002/pro.3235. PMID: 28710774.
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, Meng EC, Couch GS, Croll TI, Morris JH, Ferrin TE. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70–82. doi:10.1002/pro.3943. PMID: 32881101.
   PubMed Web of Science ®Google Scholar
• Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Žídek A, Potapenko A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–89. doi:10.1038/s41586-021-03819-2. PMID: 34265844.
   PubMed Web of Science ®Google Scholar
• Krieger E, Koraimann G, Vriend G. Increasing the precision of comparative models with YASARA NOVA - A self-parameterizing force field. Proteins Struct Funct Genet. 2002;47(3):393–402. doi:10.1002/prot.10104. PMID: 11948792.
   PubMed Web of Science ®Google Scholar
• van Zundert GCP, Bonvin AMJJ. DisVis: quantifying and visualizing accessible interaction space of distance-restrained biomolecular complexes. Bioinformatics. 2015;31(19):3222–24. doi:10.1093/bioinformatics/btv333. PMID: 26026169.
   PubMed Web of Science ®Google Scholar
• van Zundert GCP, Trellet M, Schaarschmidt J, Kurkcuoglu Z, David M, Verlato M, Rosato A, Bonvin AMJJ. The DisVis and PowerFit web servers: explorative and integrative modeling of biomolecular complexes. J Mol Biol. 2017;429(3):399–407. doi:10.1016/j.jmb.2016.11.032. PMID: 27939290.
   PubMed Web of Science ®Google Scholar
• Leitner A, Walzthoeni T, Kahraman A, Herzog F, Rinner O, Beck M, Aebersold R. Probing native protein structures by chemical cross-linking, mass spectrometry, and bioinformatics. Mol Cell Proteomics. 2010;9(8):1634–49. doi:10.1074/mcp.R000001-MCP201. PMID: 20360032.
   PubMed Web of Science ®Google Scholar